Biocytogen Pharmaceuticals (Beijing) Co., Ltd. (HKG:2315)

Market Cap	12.78B
Revenue (ttm)	1.30B
Net Income (ttm)	144.88M
Shares Out	399.40M
EPS (ttm)	0.36
PE Ratio	87.69
Forward PE	n/a
Dividend	n/a
Ex-Dividend Date	n/a

Volume	321,000
Average Volume	556,304
Open	31.96
Previous Close	32.00
Day's Range	28.12 - 31.98
52-Week Range	5.67 - 34.00
Beta	0.10
RSI	60.64
Earnings Date	Nov 28, 2025

About HKG:2315

Biocytogen Pharmaceuticals (Beijing) Co., Ltd., a biotechnology company, engages in the research and development of novel antibody-based drugs and pre-clinical research services in the People’s Republic of China, the United States, and internationally. It operates through Five segments: Gene-editing services, Pre-clinical pharmacology and efficacy evaluation, Animal models selling, Antibody development, and Innovative drugs development. The Gene-editing services segment provides the customized gene editing services based on animals as well as c...

• Industry: Biotechnology
• Sector: Healthcare
• Founded: 2008
• Employees: 1,117
• Stock Exchange: Hong Kong Stock Exchange
• Ticker Symbol: 2315

Financial Performance

Financial numbers in CNY